Patent applications published 9 June 2010
Selected patent applications from the weekly European Patents Bulletin
- Protein kinase C-inhibitors that protect against cellular injury and inflammation and promote astrocyte proliferation
Kai Pharmaceuticals 2192834*
- Treatment of lung cancer
Sciclone Pharmaceuticals 2192835*
- Heterocyclic inhibitors of necroptosis
President and Fellows of Harvard College’ The Brigham and Women’s Hospital; Trustees of Boston University; Tufts University 2192838*
- Pulsatile gastric retentive dosage forms
Depomed 2192892*
- Antifungal compsn
Basilea Pharmaceutica 2192893*
- Novel method for producing dry hydrodispersible pharmaceutical forms
Coretecholding 2192894*
- Transdermal therapeutic system containing elongate hollow bodies
LTS Lohmann Therapie-Systeme 2192895*
- Carbonylamino derivatives useful for the treatment of certain inflammatory disorders
NeuroSearch 2192896*
- Compsn and method for increasing the anabolic state of muscle cells
Northern Innovations and Formulations 2192898*
- Transition metal complexes of corroles for preventing cardiovascular diseases or disorders
Technion Research and Development Foundation 2192899*
- Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
Janssen Pharmaceutica 2192900*
- Chemicals, compsns and methods for treatment and prevention of orthopoxvirus infections and associated diseases
Siga Technologies 2192901*
- Quinoline derivatives as P13 kinase inhibitors
GlaxoSmithKline 2192902*
- Compsn and method for treatment or prevention of benign hyperplasia and lower urinary tract symptoms
Dong-A-Pharm 2192903*
- Methods for inhibiting TGF
Auxagen; St Louis University 2192904*
- Method for selective therapy of disease
Lubin, Adam; Lubin, Martin 2192905*
- Delayed self-gelling alginate systems and uses thereof
FMC Corp 2192906*
- Erythropoietin and fibronectin compsns for therapeutic and cosmetic applications
Remedor Biomed 2192907*
- Differentiation of multi-lineage progenitor cells to chondrocytes
BioE 2192908*
- Modulation of tissue fatty acid compsn of a host by human gut bacteria
University College of Cork-National University of Ireland; TEAGASC, the Agriculture and Food Development Authority; Alimentary Health 2192909*
- Oral compsns containing botanical extracts
Colgate-Palmolive 2192910*
- Plant extract from low-THC cannabis for the treatment of disease
Kläger, Regina; Kläger, Rudolph 2192911*
- Essential oil of Kunzea ambigua and methods of use
Hood, John James David 2192912*
- Compsn and methods for treating demodex infestations
TissueTech 2192913*
- Polymeric linkers containing pyridyl disulphide moieties
Enzon Pharmaceuticals 2192914*
- Therapeutic uses of peptides YSAYPDSVPMMS and WMNSTGFTKVCGAPPC
Mondobiotech Laboratories 2192915*
- Modulation of synaptogenesis
The Board of Trustees of the Leland Stanford Junior University 2192916*
- Method of producing viral vaccines
Baxter International; Baxter Healthcare 2192917*
- HIV ENV proteins with modifications in the V3 loop
Novartis 2192918*
- Methods of inhibiting tumour growth using beta 5 integrin antagonists
University Health Network 2192919*
- Methods and compsns for treatment or prevention of radiation-induced fibrosis
Virginia Commonwealth University Intellectual Property Foundation 2192920*
- Intraoperative trifunctional antibody administration for prophylaxis or intraperitoneal tumour cell dissemination
Trion Pharma 2192921*
- Internalising human monoclonal antibodies targeting prostate cancer cells in situ
The Regents of the University of California 2192922*
- Bi-functional polymer-attached inhibitors of influenza virus
Massachusetts Institute of Technology 2192923*
- Saccharide-containing protein conjugates and uses thereof
Protalix 2192924*
- Targeting RNA with external guide sequences
Keren Pharmaceuticals 2192925*
- Self-complementary AAV-mediated delivery of interfering RNA molecules to treat or prevent ocular disorders
Alcon Research 2192926*
- Ed-B fibronectin as stratification marker for anti-tumour drugs
Bayer Schering Pharma Aktiengesellschaft 2192927*
- Perfluoro-aryliodonium salts in nucleophilic aromatic 18F-fluorination
GE Healthcare 2192928*